PromoCell launches GMP cell culture media services for clinical therapy applications
PromoCell GmbH, the Heidelberg-based manufacturer of primary human cells and specialised cell culture media, has announced its entry into the Good Manufacturing Practice (GMP) arena with a new service portfolio designed for cell-based therapy and regenerative medicine applications. The company debuted its Custom GMP Cell Culture Media Services at the 32nd European Society of Gene and Cell Therapy Congress in Seville in October 2025.
Bridging research and clinical translation
The new service offering centres on Excipient GMP-grade cell culture media manufacturing, providing both off-the-shelf and customised solutions that comply with regulatory standards for clinical applications. This expansion addresses growing demand within the cell therapy sector for advanced culture media that can support the transition from research-grade to clinical-grade production processes.
Dr Irma Börcsök, chief executive of PromoCell, said: “We noticed an increasing demand for advanced cell culture media in regenerative medicine and cell-based therapy, and we are thrilled to introduce our GMP cell culture medium service portfolio to the life science community at the ESGCT Congress. This launch is a testament to our dedication to supporting customers with our long-standing cell culture medium expertise every step of the way, from discovery to preclinical, clinical, and commercial manufacturing.”
Quality-controlled manufacturing infrastructure
The GMP-grade designation refers to reagents manufactured at PromoCell’s Heidelberg facility under controlled processes meeting specific product specifications and customer requirements. The company has also developed its PromoExQ product portfolio to support clinical applications.
Dr Lucía Cespón, GMP Business Unit Lead at PromoCell, noted: “We’ve worked closely with our clients in clinical applications to ensure that both our Custom GMP Cell Culture Media Services and our advanced cell culture media product portfolio ‘PromoExQ’ ensure the precision, flexibility, and compliance that modern translational research demands.”
Founded in 1990, PromoCell serves academic, clinical, and biopharmaceutical clients globally.
For more information, visit: www.promocell.com
